School administrators and nurses are encouraged to review applicable state laws and regulations to ensure neffy® (epinephrine nasal spray) 2 mg ...
Those who rely on EpiPens during an allergic reaction may have a new alternative to reach for, after the U.S. Food and Drug ...
neffy 2 mg is for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh ≥30 kg (66 lbs.). It is the first and only FDA-approved epinephrine nasal ...
A second dose may be given if needed, similar to injectable epinephrine, the agency said. Neffy uses the same spray device as ...
Preliminary fourth quarter neffy® net product revenue of approximately $6.5 millionPreliminary cash, cash equivalents and short-term investments ...
Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...
neffy is the first FDA-approved epinephrine nasal spray, offering a needle-free alternative and enhancing patient safety and compliance during emergency situations. The company's commitment to ...
ARS Pharmaceuticals, Inc. announced that its licensing partners in China, Japan, and Australia have applied for approval of neffy® (epinephrine nasal spray) 2 mg, which is already approved in the ...